Miikana therapeutics

Author: wlxt

August undefined, 2024

WebAbout Miikana Therapeutics. Miikana has built an oncology pipeline through a strategy that included both in-licensing clinical and preclinical compounds with distinct mechanisms of … WebThe MIIKANA trademark was assigned a Serial Number # 78927960 – by the United States Patent and Trademark Office (USPTO). Trademark Serial Number is a unique ID to …

MIIKANATHERAPEUTICSINC - 회사 기술 포트폴리오, 회사 …

Webprofiles.biocentury.com Web17 nov. 2005 · Assignee: Miikana Therapeutics, Inc. Inventors: Xiao-Yi Xiao, Dinesh V. Patel Inhibitors of histone deacetylase. Patent number: 7345043 Abstract: Disclosed are … balti aktsiad

Executive Team - Protagonist Therapeutics Inc.

WebHe has had a uniquely distinguished career in the life science industry having participated in the development of multiple blockbuster oncology therapeutics while Vice President of … WebWho We Are. Our circle is made up of both Indigenous and non-Indigenous experts who believe in building sustainable mutually beneficial partnerships. Our combined … WebMiikana Therapeutics Inc The Company specializes in discovery and development of medicines for the treatment of cancer. Miikana Therapeutics conducts business in the … armani casa miami beach

EntreMed, Inc. To Acquire Miikana Therapeutics BioSpace

Miikana Therapeutics CEO, Founder, Key Executive Team, Board of ...

WebMiikana Therapeutics Inc., a biopharmaceutical company with joint research operations in the Bay Area, California and Toronto, Canada, announced today that it had completed a … WebMiikana Therapeutics Information Developer of medicines for cancer treatment. The company develops its products through internal drug discovery programs, as well as by … baltiaaWebPreviously, he was the Chief Executive Officer and Co-founder of Miikana Therapeutics, an oncology based company, from 2003 until acquired by Entremed (later renamed CASI … baltian kartta

"WebMiikana Therapeutics Inc. (Corporation# 6007694) is a federal corporation entity registered with Corporations Canada. The incorporation date is July 26, 2002. The principal … " - Miikana therapeutics

Miikana therapeutics

WebMiikana - Fremont, California and Toronto, Ontario NovImmune - Geneva, Switzerland November 4, 2003 - Miikana Therapeutics Inc. and NovImmune SA have established a … Web1 jun. 2013 · Miikana Therapeutics Inc. Jun 2002 - Feb 2003 9 months. Co-founder of Toronto based start up company specializing in cancer …

Did you know?

WebThe corporation name Miikana Therapeutics Inc.. Business Information. Director Name: SCOTT M. ROCKLAGE : Address: 179 Sandy Pond Road Lincoln MA 01773 : …

WebMIIKANA THERAPEUTICS INC. is a California Stock Corporation - Out Of State - Stock filed on July 15, 2004. The company's filing status is listed as Forfeited - Ftb and its File … Web5 aug. 2024 · Targeted delivery of oligonucleotides to liver hepatocytes using N-acetylgalactosamine (GalNAc) conjugates that bind to the asialoglycoprotein receptor …

WebMIIKANA THERAPEUTICS INC has a total of 37 patent applications. Its first patent ever was published in 2005. It filed its patents most often in Australia, EPO (European Patent … WebROCKVILLE, MD, – December 22, 2005 – EntreMed, Inc. (NASDAQ:ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that it has entered into a definitive merger agreement under which it will acquire all of the outstanding capital stock of Miikana …

Web15 jul. 2004 · MIIKANA THERAPEUTICS INC. branch Company Number 2666534 Previous Company Numbers C2666534 Status Forfeited Ftb Incorporation Date 15 July 2004 …

Web대표 회사명칭: MIIKANATHERAPEUTICSCORP "Miikana Therapeutics Corporation"라는 출원인 명칭으로 US (미국) 특허청에 가장 많은 출원을 하고 있습니다 (3건) 최근에 가장 … baltian maihinThe Prosetta Platform has been applied to infectious and degenerative diseases alike, including: Respiratory viruses (including coronaviridae); Amyotrophic Lateral Sclerosis (ALS); Oncology; Human Immunodeficiency Virus (HIV); Parkinson’s Disease. baltian maatWebMiikana Therapeutics was acquired by CASI Pharmaceuticals on January 10, 2006. Life ScienceCompany. Out of 60 sectors in the Mergr database, life science ranked 9 in … armani casa table diningWeb15 jul. 2004 · MIIKANA THERAPEUTICS INC. branch Company Number 2666534 Previous Company Numbers C2666534 Status Forfeited Ftb Incorporation Date 15 July 2004 (over 18 years ago) Dissolution Date 1 May 2008 Company Type Stock Corporation - Out of State - Stock Jurisdiction California (US) Branch Branch of MIIKANA THERAPEUTICS INC. … baltianWebDinesh V. Patel previously was President & Chief Executive Officer for Arête Therapeutics, Inc., Medicinal Chemist at Bristol Myers Squibb Co., Chemistry Director at Affymax, Inc., … baltian parhaat rannatWeb14 okt. 2024 · With more than 35 years in the biotech and pharmaceutical industry, I’ve been a proud member of the discovery and development teams at large pharma and biotech companies, have founded multiple biotechs that I saw through to acquisition by large companies, and served as CEO of three. baltia meridaWebIn December, 2005, Miikana was sold to Entremed for $21 million plus milestones. Since 2003, I have focused my attention on open source synthetic biology. Part of my broad education and outreach agenda includes the founding of … armani clark obituary